Nektar Therapeutics (NASDAQ:NKTR)

33.70
Delayed Data
As of 4:00pm ET
 +0.30 / +0.90%
Today’s Change
29.22
Today|||52-Week Range
69.76
+2.53%
Year-to-Date

Today’s Trading

Previous close33.40
Today’s open33.80
Day’s range33.30 - 34.24
Volume906,995
Average volume (3 months)1,673,080
Market cap$5.8B
Data as of 4:00pm ET, 06/17/2019

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-181.05%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+287.81%
P/E ratio9.1
Price/Sales4.96
Price/Book3.37

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc+5.04+4.28%
MRNAModerna Inc+0.37+2.40%
BPMCBlueprint Medicines ...+3.74+4.12%
NBIXNeurocrine Bioscienc...+2.10+2.50%
Data as of 4:00pm ET, 06/17/2019

Financials

Next reporting dateAugust 5, 2019
EPS forecast (this quarter)-$0.80
Annual revenue (last year)$1.2B
Annual profit (last year)$681.3M
Net profit margin57.09%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts